Preliminary Clinical Trial of Cybernotic Disease Transmission via Photodynamics.
Global dissemination of a zoonotic virus pandemic narrative by the WHO, government and university scientists, the media, and the general public, has enabled the trialling of a cybernosis, or disease transmitted from a computing machine to humans, amongst a new and relatively large target body. This paper presents the rationale, methodology, initial findings, and limitations of the preliminary trial, and assesses the future potential of this new field of virology.
The widescale dissemination, via government bodies (e.g., SAGE, SPI-B, CDC), NGOs (e.g., WEF, WHO, World Bank, IMF), universities, individuals, and most credible media organizations (e.g., Reuters, Guardian, New York Times, Der Spiegel, BBC), of the Sars-CoV-2 pandemic narrative brought about the anticipated largescale uptake (currently 4.9 billion people) of the new mRNA genetic modification technique.
Whilst the ‘vaccine’ programme has been highly successful (and should soon incorporate most humans above six months of age) as yet it is not universal, requiring ongoing coercive stimuli and alternative rollouts (e.g., polio, smallpox, seasonal influenza). A significant residue of unvaccinated individuals is likely to persist (also anticipated), a cohort that often correlates with narrative scepticism, and even the promulgation of a counter-narrative.
Pandemic scepticism and attendant vaccine resistance have various causes. So far, an algorithm for predicting or identifying recalcitrance or ‘free thinking’ is unavailable. However, one of the drivers of what has been termed ‘sheer bloody-mindedness’ (Hoff et al., 2009) is people turning to alternative media sites for authentic journalism (e.g., Global Research, Signs of the Times, UK Column News, Off Guardian).